Psilocybin for OCD: Terence Ching on lessons from Yale's randomized trials

Psilocybin for OCD is discussed through lessons from Yale's randomized clinical trials. Terence Ching focuses on what these studies suggest about how psilocybin-assisted treatment might affect obsessive-compulsive symptoms, and what patterns in outcomes or study design can inform future research. The discussion also highlights practical takeaways for translating trial insights into later work, including how to think about evidence, patient selection, and study conditions when moving from controlled results toward broader mental health applications.